Surmodics (SRDX) Earnings Date, Estimates & Call Transcripts $35.41 +0.40 (+1.14%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$35.42 +0.01 (+0.01%) As of 08/8/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Surmodics Earnings Summary Surmodics released Q3 2025 earnings on August 8, 2025, reporting an EPS of $0.06, which topped analysts' consensus estimates of -$0.21 by $0.27. Quarterly revenue was reported to be $29.57 million, above the consensus estimate of $28.04 million. With a trailing EPS of -$1.23, Surmodics' earnings are expected to grow 300.00% next year, from $0.20 to $0.80 per share. Latest Q3 Earnings DateAug. 8EstimatedConsensus EPS (Aug. 8) -$0.21 Actual EPS (Aug. 8) $0.06 Beat By $0.27 Actual Revenue (Aug. 8) $29.57MQ3 2025 Earnings ResourcesQ3 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)Powered by Get Surmodics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Surmodics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSRDX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SRDX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Surmodics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue GuidanceQ1 20252-$0.11-$0.09-$0.10Q2 20252-$0.04$0.00-$0.02Q3 20252-$0.21-$0.21-$0.21Q4 20252-$0.18-$0.18-$0.18 FY 2025 8 -$0.54 -$0.48 -$0.51 Q1 20262-$0.18-$0.18-$0.18Q2 20262$0.01$0.01$0.01Q3 20262$0.01$0.01$0.01Q4 20262$0.07$0.07$0.07 FY 2026 8 -$0.09 -$0.09 -$0.09 Q1 20271$0.00$0.00$0.00Q2 20271$0.11$0.11$0.11 Surmodics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails8/8/2025Q3 2025-$0.21$0.06+$0.27-$0.37$28.04M$29.57M4/30/2025Q2 2025-$0.06-$0.13 -$0.07-$0.36$32.23M$28.09M2/6/2025Q1 2025-$0.08-$0.04+$0.04-$0.26$33.37M-11/6/2024--$0.27-$0.13+$0.14-$0.02$30.69M$33.23M7/31/2024Q3 2024-$0.31-$0.27+$0.04-$0.01$30.32M$30.34M5/1/2024Q2 2024-$0.36$0.07+$0.43$0.12$28.79M$31.96M11/8/2023Q4 2023$0.16$0.53+$0.37$0.59$26.00M$27.97M Surmodics Earnings - Frequently Asked Questions When did Surmodics announce their last quarterly earnings? Surmodics (NASDAQ:SRDX) last announced its quarterly earning data on Friday, August 8, 2025. Learn more on SRDX's earnings history. What guidance has Surmodics issued on next quarter's earnings? Surmodics issued an update on its FY 2025 earnings guidance on Friday, August, 8th. The company provided earnings per share (EPS) guidance of -0.350--0.200 for the period, compared to the consensus earnings per share estimate of -0.546. The company issued revenue guidance of $116.5 million-$118.5 million, compared to the consensus revenue estimate of $115.7 million. Did Surmodics beat their earnings estimates last quarter? In the previous quarter, Surmodics (NASDAQ:SRDX) reported $0.06 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.21) by $0.27. Learn more on analysts' earnings estimate vs. SRDX's actual earnings. How much revenue does Surmodics generate each year? Surmodics (NASDAQ:SRDX) has a recorded annual revenue of $121.58 million. How much profit does Surmodics generate each year? Surmodics (NASDAQ:SRDX) has a recorded net income of -$11.54 million. SRDX has generated -$1.23 earnings per share over the last four quarters. What is Surmodics' EPS forecast for next year? Surmodics' earnings are expected to grow from $0.20 per share to $0.80 per share in the next year, which is a 300.00% increase. More Earnings Resources from MarketBeat Related Companies Alphatec Earnings Results AtriCure Earnings Results Integra LifeSciences Earnings Results Orthofix Medical Earnings Results AngioDynamics Earnings Results Accuray Earnings Results Rockwell Medical Earnings Results ReShape Lifesciences Earnings Results Abbott Laboratories Earnings Results Intuitive Surgical Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Airbnb Beats Earnings, But the Growth Story Is Losing AltitudeDutch Bros Just Flipped the Script With a Massive Earnings BeatIs Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity?Constellation Energy’s Earnings Beat Signals a New EraRealty Income Rallies Post-Earnings Miss—Here’s What Drove ItDon't Mix the Signal for Noise in Super Micro Computer's EarningsWhy Monolithic Power's Earnings and Guidance Ignited a Rally This page (NASDAQ:SRDX) was last updated on 8/11/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surmodics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surmodics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access Sale